Table 1.
Clinical characteristics of patients with and without infection
| Infection (n = 20) | No infection (n = 36) | P | |
|---|---|---|---|
| Female | 11 (55.0) | 19 (52.8) | 0.873 |
| Malea | 9 (45.0) | 17 (47.2) | |
| Age (years)b | 78 (63; 83) | 70 (62; 79) | 0.141 |
| Stroke subtype | 0.006c | ||
| Cardiogenic embolisma | 13 (65.0) | 7 (19.4) | |
| Large artery occlusiona | 2 (10.0) | 10 (27.8) | |
| Lacunar infarctiona | 1 (5.0) | 9 (25.0) | |
| Unknowna | 4 (20.0) | 10 (27.8) | |
| Hypertensiona | 17 (85.0) | 22 (61.1) | 0.062 |
| Smokera | 4 (20.0) | 5 (13.9) | 0.551 |
| Hyperlipoproteinemiaa | 6 (30.0) | 14 (39.9) | 0.506 |
| Creatinine (μmol/L)b | 76 (63; 87) | 80 (69; 96) | 0.293 |
| eGFR (ml/min per 1.73 m2)b | 78 (60; 88) | 71 (60; 90) | 0.918 |
| Diabetes mellitusa | 8 (40.0) | 8 (22.2) | 0.158 |
| NIHSS on admissionb | 15 (9; 18) | 3 (1; 8) | <0.001c |
| NIHSS 90db | 6 (3; 34) | 1 (0; 3) | <0.001c |
| WBC 1d (1000/μl)b | 8.2 (6.6; 8.8) | 7.2 (6.4; 8.1) | 0.074 |
| S100B peak levels (μg/l)b | 0.21 (0.12; 0.69) | 0.11 (0.09; 0.24) | 0.011c |
| i.v. rt-PAa | 6 (30.0) | 9 (25.0) | 0.686 |
eGFR, estimated glomerular filtration rate; NIHSS, National Institutes of Health Stroke Scale; i.v. rt-PA, intravenous recombinant tissue-type plasminogen activator; WBC, white blood cell count.Data are presented as numbers (percentages) a or median (interquartile range) b. P <0.05 was considered statistically significant c.